EMD Millipore (Merck KGaA), Avantor Performance Materials and Thermo Fisher Scientific, Inc, are Dominating the Market for Global Chromatography Solvents Market in 2017

Merck KGaA

The company was founded in 1995, headquarter in Darmstadt, Germany. The company involved in provides tools, technologies and innovative solutions for bioscience research and biopharmaceutical companies. The main business segments of the company are healthcare, life science and performance materials.  The revenue of the company is USD 17,922.2 Million.  Number of employees is 52,941. The company has global presence in Asia-Pacific, Europe, North America, South America, Middle East and Africa.

  • In 2014, Sigma-Aldrich (U.S.) merged with Merck (Europe) to increase its product base in pharmaceutical, chemical and life science sectors. This will help company to increase its revenue and grow rapidly.

Access Full Report at https://databridgemarketresearch.com/reports/global-chromatography-solvents-market/

Avantor Inc.

Medtronic was founded in 1904 and headquartered at Pennsylvania, U.S. The company is engaged in manufacturing and distribution of high quality products, services and solutions to life sciences and advanced technology industries.. The market focused segments are gas chromatography solvents & reagents, HPLC solvents & reagents, LC/MS solvents & reagents and UHPLC solvents. . The company has its presence in United States, Mexico, Netherlands, Poland, India, Malaysia, Korea, China, Taiwan

  • In 2017, Avantor Inc (U.S.) acquired VWR corporation to enhance long term industry dynamics to accelerate the growth of the market. With this acquisition, avantor’s high purity materials will enable the organization to meet the customer requirements globally.

THERMO FISHER SCIENTIFIC INC.

Founded in 2008 and headquartered in Waltham, U.S. The company involved in helping customers accelerate life science research, solve complex analytical challenges, deliver medicines to market, increase laboratory productivity and improve patient diagnostics. The main business segments of the company are laboratory products & services, life science solutions, analytical instruments and speciality diagnostics. .  The revenue of the company is USD 20,918 Million.  Number of employees is 70,000. The company has global presence in The North America, Europe, Asia-Pacific and Rest of the world.

  • In 2018, Thermo Fisher Scientific acquired advanced bioprocessing business from Becton, Dickinson and Company (U.S.) to enhance cell culture media formulations to reduce variability and improve yield in biopharmaceutical applications. Hence with the increasing biopharmaceutical applications, the company will generate more revenue.